In vivo models of diabetic retinopathy

Experimental Approaches to Diabetic Retinopathy

Volumn 20, Issue , 2009, Pages 42-60

  Zheng, Ling ^a   Kern, Timothy S ^b,c  

^a WUHAN UNIVERSITY   (China)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77956961276     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1159/000262661     Document Type: Chapter

References (174)

1. Davis MD, Kern TS, Rand LI: Diabetic Retinopathy; in Alberti KGMM, Zimmet P, DeFronzo RA (eds): International Textbook of Diabetes Mellitus, ed 2. New York, John Wiley & Sons, 1997, pp 1413-1446.
2. Cunha-Vaz J, Faria de Abreu JR, Campos AJ: Early breakdown of the bloodretinal barrier in diabetes. Br J Ophthalmol 1975;59:649-656.
3. Kohner EM, Henkind P: Correlation of fluorescein angiogram and retinal digest in diabetic retinopathy. Am J Ophthalmol 1970;69:403-414.
4. Ashton N: Pathogenesis of diabetic retinopathy; in Little HLJR, Patz A, Forsham PH (ed): Diabetic Retinopathy. New York, Thieme-Stratton Inc., 1983, pp 85-106.
5. Aguilar E, Friedlander M, Gariano RF: Endothelial proliferation in diabetic retinal microaneurysms. Arch Ophthalmol 2003;121:740-741.
6. Engerman RL: Pathogenesis of diabetic retinopathy. Diabetes 1989;38:1203-1206.
7. Roy S, Sato T, Paryani G, Kao R: Downregulation of fibronectin overexpression reduces basement membrane thickening and vascular lesions in retinas of galactose-fed rats. Diabetes 2003;52:1229-1234.
8. Cogan DG, Kuwabara T: The mural cell in perspective. Arch Ophthalmol 1967;78:133-139.
9. Mizutani M, Kern TS, Lorenzi M: Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy. J Clin Invest 1996;97:2883-2890.
10. Hammes HP, Lin J, Wagner P, Feng Y, Vom Hagen F, Krzizok T, Renner O, Breier G, Brownlee M, Deutsch U: Angiopoietin-2 causes pericyte dropout in the normal retina: evidence for involvement in diabetic retinopathy. Diabetes 2004;53:1104-1110.
11. Feit-Leichman RA, Kinouchi R, Takeda M, Fan Z, Mohr S, Kern TS, Chen DF: Vascular damage in a mouse model of diabetic retinopathy: relation to neuronal and glial changes. Invest Ophthalmol Vis Sci 2005;46:4281-4287.
12. Cogan DG, Toussaint D, Kuwabara T: Retinal vascular patterns. IV. Diabetic retinopathy. Arch Ophthalmol 1961;66:366-378.
13. Kuwabara T, Cogan DG: Retinal vascular patterns. VI. Mural cells of the retinal capillaries. Arch Ophthalmol 1963;69:492-502.
14. Cuthbertson RA, Mandel TE: Anatomy of the mouse retina. Endothelial cellpericyte ratio and capillary distribution. Invest Ophthalmol Vis Sci 1986;27:1659-1664.
15. Danis RP, Yang Y: Microvascular retinopathy in the Zucker diabetic fatty rat. Invest Ophthalmol Vis Sci 1993;34:2367-2371.
16. Kern TS, Engerman RL: Vascular lesions in diabetes are distributed nonuniformly within the retina. Exp Eye Res 1995;60:545-549.
17. Tang J, Mohr S, Du Y, Kern TS: Nonuniform distribution of lesions and biochemical abnormalities within the retina of diabetic humans. Curr Eye Res 2003;27:7-13.
18. Danis RP, Wallow IL: HRP/trypsin technique for studies of the retinal vasculature. Invest Ophthalmol Vis Sci 1986;27:434-437.
19. Penn JS, Gay CA: Computerized digital image analysis of retinal vessel density: application to normoxic and hyperoxic rearing of the newborn rat. Exp Eye Res 1992;54:329-336.
20. D'Amato R, Wesolowski E, Smith LE: Microscopic visualization of the retina by angiography with high-molecularweight fluorescein-labeled dextrans in the mouse. Microvasc Res 1993;46:135-142.
21. Ben-nun J, Alder VA, Constable IJ: Retinal microvascular patency in the diabetic rat. Int Ophthalmol 2004;25:187-192.
22. Kuwabara T, Cogan DG: Studies of retinal vascular patterns: I. Normal architecture. Arch Ophthalmol 1960;64:904-911.
23. Laver NM, Robison WG Jr, Pfeffer BA: Novel procedures for isolating intact retinal vascular beds from diabetic humans and animal models. Invest Ophthalmol Vis Sci 1993;34:2097-2104.
24. Kowluru RA, Jirousek MR, Stramm LE, Farid NA, Engerman RL, Kern TS: Abnormalities of retinal metabolism in diabetes or experimental galactosemia. V. Relationship between protein kinase C and ATPases. Diabetes 1998;47:464-469.
25. Badr GA, Tang J, Ismail-Beigi F, Kern TS: Diabetes down-regulates Glut1 expression in retina and its microvessels, but not in cerebral cortex or its microvessels. Diabetes 2000;49:1016-1021.
26. Zheng L, Szabo C, Kern TS: Poly(ADPribose) polymerase is involved in the development of diabetic retinopathy via regulation of nuclear factor-kappaB. Diabetes 2004;53:2960-2967.
27. Podesta F, Romeo G, Liu WH, Krajewski S, Reed JC, Gerhardinger C, Lorenzi M: Bax is increased in the retina of diabetic subjects and is associated with pericyte apoptosis in vivo and in vitro. Am J Pathol 2000;156:1025-1032.
28. Dagher Z, Park YS, Asnaghi V, Hoehn T, Gerhardinger C, Lorenzi M: Studies of rat and human retinas predict a role for the polyol pathway in human diabetic retinopathy. Diabetes 2004;53:2404-2411.
29. Bresnick GM, Palta M: Predicting progression of severe proliferative diabetic retinopathy. Arch Ophthalmol 1987;105:810-814.
30. Bresnick GH, Palta M: Oscillatory potential amplitudes: Relation to severity of diabetic retinopathy. Arch Ophthalmol 1987;105:929-933.
31. Falsini B, Porciatti V, Scalia G, Caputo S, Minnella A, Di Leo MA, Ghirlanda G: Steady-state pattern electroretinogram in insulin-dependent diabetics with no or minimal retinopathy. Doc Ophthalmol 1989;73:193-200.
32. Caputo S, Di Leo MA, Falsini B, Ghirlanda G, Porciatti V, Minella A, Greco AV: Evidence for early impairment of macular function with pattern ERG in type I diabetic patients. Diabetes Care 1990;13:412-418.
33. Prager TC, Garcia CA, Mincher CA, Mishra J, Chu HH: The pattern electroretinogram in diabetes. Am J Ophthalmol 1990;109:279-284.
34. Rungger-Brandle E, Dosso AA, Leuenberger PM: Glial reactivity, an early feature of diabetic retinopathy. Invest Ophth Vis Sci 41:1971-1980, 2000.
35. Carrasco E, Hernandez C, de Torres I, Farres J, Simo R: Lowered cortistatin expression is an early event in the human diabetic retina and is associated with apoptosis and glial activation. Mol Vis 2008;14:1496-1502.
36. Engerman RL, Meyer RK, Buesseler JA: Effects of alloxan diabetes and steroid hypertension on retinal vasculature. Am J Ophthalmol 1964;58:965-978.
37. Toussaint D: Contribution a l'etude anatomique et clinque de la retinopathie diabetique chez l'homme et chez l'animal. Pathologia Eur 1968:108-148.
38. Engerman RL, Finkelstein D, Aguirre G, Diddie K, Fox R, Frank R, Varma S: Appropriate animal models for research on human diabetes mellitus and its complications. Ocular complications. Diabetes 1982;31(suppl 1):82-88.
39. Engerman RL, Kern TS: Retinopathy in animal models of diabetes. Diabetes Metab Rev 1995;11:109-120.
40. Engerman RL, Bloodworth JMB Jr: Experimental diabetic retinopathy in dogs. Arch Ophthalmol 1965;73:205-210.
41. Engerman RL, Kern TS: Aldose reductase inhibition fails to prevent retinopathy in diabetic and galactosemic dogs. Diabetes 1993;42:820-825.
42. Ashton N: Arteriolar involvement in diabetic retinopathy. Br J Ophthalmol 1953;37:282-292.
43. Gardiner TA, Stitt AW, Anderson HR, Archer DB: Selective loss of vascular smooth muscle cells in the retinal microcirculation of diabetic dogs. Br J Ophthalmol 1994;78:54-60.
44. Hatchell DL, Braun RD, Lutty GA, McLeod DS, Toth CA: Progression of diabetic retinopathy in a cat. Invest Ophthalmol Vis Sci 1995;36:S1067.
45. Linsenmeier RA, Braun RD, McRipley MA, Padnick LB, Ahmed J, Hatchell DL, McLeod DS, Lutty GA: Retinal hypoxia in long-term diabetic cats. Invest Ophthalmol Vis Sci 1998;39:1647-1657.
46. Engerman RL, Bloodworth JMB Jr, Nelson S: Relationship of microvascular disease in diabetes to metabolic control. Diabetes 1977;26:760-769.
47. Engerman RL, Kern TS: Progression of incipient diabetic retinopathy during good glycemic control. Diabetes 1987;36:808-812.
48. Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-986.
49. United Kingdom Prospective Diabetes Study: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet 1998;352:837-853.
50. Wallow IH, Engerman RL: Permeability and patency of retinal blood vessels in experimental diabetes. Invest Ophthalmol 1977;16:447-461.
51. Kern TS, Tang J, Mizutani M, Kowluru RA, Nagaraj RH, Romeo G, Podesta F, Lorenzi M: Response of capillary cell death to aminoguanidine predicts the development of retinopathy: comparison of diabetes and galactosemia. Invest Ophthalmol Vis Sci 2000;41:3972-3978.
52. Kowluru RA, Tang J, Kern TS: Abnormalities of retinal metabolism in diabetes and experimental galactosemia. VII. Effect of long-term administration of antioxidants on the development of retinopathy. Diabetes 2001;50:1938-1942.
53. Joussen AM, Poulaki V, Le ML, Koizumi K, Esser C, Janicki H, Schraermeyer U, Kociok N, Fauser S, Kirchhof B, Kern TS, Adamis AP: A central role for inflammation in the pathogenesis of diabetic retinopathy. FASEB J 2004;18:1450-1452.
54. Yu DY, Cringle SJ, Su EN, Yu PK, Jerums G, Cooper ME: Pathogenesis and intervention strategies in diabetic retinopathy. Clin Experiment Ophthalmol 2001;29:164-166.
55. Chakrabarti S, Zhang WX, Sima AA: Optic neuropathy in the diabetic BBrat. Adv Exp Med Biol 1991;291:257-264.
56. Sima AA, Zhang WX, Cherian PV, Chakrabarti S: Impaired visual evoked potential and primary axonopathy of the optic nerve in the diabetic BB/Wrat. Diabetologia 1992;35:602-607.
57. Kamijo M, Cherian PV, Sima AAF: The preventive effect of aldose reductase inhibition on diabetic optic neuropathy in the BB/W rat. Diabetologia 1993;36:893-898.
58. Hammes HP, Federoff HJ, Brownlee M: Nerve growth factor prevents both neuroretinal programmed cell death and capillary pathology in experimental diabetes. Mol Med 1995;1:527-534.
59. Barber AJ, Lieth E, Khin SA, Antonetti DA, Buchanan AG, Gardner TW: Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin. J Clin Invest 1998;102:783-791.
60. Lieth E, Gardner TW, Barber AJ, Antonetti DA: Retinal neurodegeneration: early pathology in diabetes. Clin Experiment Ophthalmol 2000;28:3-8.
61. Agardh E, Bruun A, Agardh CD: Retinal glial cell immunoreactivity and neuronal cell changes in rats with STZinduced diabetes. Curr Eye Res 2001;23:276-284.
62. Aizu Y, Oyanagi K, Hu J, Nakagawa H: Degeneration of retinal neuronal processes and pigment epithelium in the early stage of the streptozotocin-diabetic rats. Neuropathology 2002;22:161-170.
63. Asnaghi V, Gerhardinger C, Hoehn T, Adeboje A, Lorenzi M: A role for the polyol pathway in the early neuroretinal apoptosis and glial changes induced by diabetes in the rat. Diabetes 2003;52:506-511.
64. Aizu Y, Katayama H, Takahama S, Hu J, Nakagawa H, Oyanagi K: Topical instillation of ciliary neurotrophic factor inhibits retinal degeneration in streptozotocin-induced diabetic rats. Neuroreport 2003;14:2067-2071.
65. Park SH, Park JW, Park SJ, Kim KY, Chung JW, Chun MH, Oh SJ: Apoptotic death of photoreceptors in the streptozotocin-induced diabetic rat retina. Diabetologia 2003;46:1260-1268.
66. Martin PM, Roon P, Van Ells TK, Ganapathy V, Smith SB: Death of retinal neurons in streptozotocin-induced diabetic mice. Invest Ophthalmol Vis Sci 2004;45:3330-3336.
67. Kern TS, Miller CM, Du Y, Zheng L, Mohr S, Ball SL, Kim M, Jamison JA, Bingaman DP: Topical administration of nepafenac inhibits diabetes-induced retinal microvascular disease and underlying abnormalities of retinal metabolism and physiology. Diabetes 2007;56:373-379.
68. Kusner LL, Sarthy VP, Mohr S: Nuclear translocation of glyceraldehyde-3-phosphate dehydrogenase: a role in high glucose-induced apoptosis in retinal Muller cells. Invest Ophthalmol Vis Sci 2004;45:1553-1561.
69. Lieth E, Barber AJ, Xu B, Dice C, Ratz MJ, Tanase D, Strother JM: Glial reactivity and impaired glutamate metabolism in short-term experimental diabetic retinopathy. Penn State Retina Research Group. Diabetes 1998;47:815-820.
70. Mizutani M, Gerhardinger C, Lorenzi M: Muller cell changes in human diabetic retinopathy. Diabetes 1998;47:445-449.
71. Barber AJ, Antonetti DA, Gardner TW: Altered expression of retinal occludin and glial fibrillary acidic protein in experimental diabetes. The Penn State Retina Research Group. Invest Ophthalmol Vis Sci 2000;41:3561-3568.
72. Zeng XX, Ng YK, Ling EA: Neuronal and microglial response in the retina of streptozotocin-induced diabetic rats. Visual Neurosci 2001;17:463-471.
73. Li Q, Zemel E, Miller B, Perlman I: Early retinal damage in experimental diabetes: electroretinographical and morphological observations. Exp Eye Res 2002;74:615-625.
74. Seki M, Tanaka T, Nawa H, Usui T, Fukuchi T, Ikeda K, Abe H, Takei N: Involvement of brain-derived neurotrophic factor in early retinal neuropathy of streptozotocin-induced diabetes in rats: therapeutic potential of brain-derived neurotrophic factor for dopaminergic amacrine cells. Diabetes 2004;53:2412-2419.
75. Sima AA, Garcia-Salinas R, Basu PK: The BB Wistar rat: an experimental model for the study of diabetic retinopathy. Metabolism 1983;32(suppl 1):136-140.
76. Sima AA, Chakrabarti S, Garcia-Salinas R, Basu PK: The BB-rat-an authentic model of human diabetic retinopathy. Curr Eye Res 4:1087-1092, 1985.
77. Chakrabarti S, Sima AAF, Tze WJ, Tai J: Prevention of diabetic retinal capillary pericyte degeneration and loss by pancreatic islet allograft. Curr Eye Res 1987;6:649-658.
78. Robison WG Jr, McCaleb ML, Feld LG, Michaelis OE, IV, Laver N, Mercandetti M: Degenerated intramural pericytes ('ghost cells') in the retinal capillaries of diabetic rats. Curr Eye Res 1991;10:339-350.
79. Shinohara M, Masuyama T, Shoda T, Takahashi T, Katsuda Y, Komeda K, Kuroki M, Kakehashi A, Kanazawa Y: A new spontaneously diabetic non-obese Torii rat strain with severe ocular complications. Int J Exp Diabetes Res 2000;1:89-100.
80. Miao G, Ito T, Uchikoshi F, Kamei M, Akamaru Y, Kiyomoto T, Komoda H, Nozawa M, Matsuda H: Stage-dependent effect of pancreatic transplantation on diabetic ocular complications in the spontaneously diabetic Torii rat. Transplantation 2004;77:658-663.
81. Yamada H, Yamada E, Higuchi A, Matsumura M: Retinal neovascularisation without ischaemia in the spontaneously diabetic Torii rat. Diabetologia 2005;48:1663-1668.
82. Nakama K, Shichinohe K, Kobayashi K, Naito K, Uchida O, Yasuhara K, Tobe M: Spontaneous diabetes-like syndrome in WBN/KOB rats. Acta Diabetol Lat 1985;22:335-342.
83. Matsuura T, Horikiri K, Ozaki K, Narama I: Proliferative retinal changes in diabetic rats (WBN/Kob). Lab Anim Sci 1999;49:565-569.
84. Bhutto IA, Miyamura N, Amemiya T: Vascular architecture of degenerated retina in WBN/Kob rats: corrosion cast and electron microscopic study. Ophthalmic Res 1999;31:367-377.
85. Miyamura N, Amemiya T: Lens and retinal changes in the WBN/Kob rat (spontaneously diabetic strain). Electron-microscopic study. Ophthalmic Res 1998;30:221-232.
86. Ogawa T, Ohira A, Amemiya T: Superoxide dismutases in retinal degeneration of WBN/Kob rat. Curr Eye Res 1998;17:1067-1073.
87. Azuma M, Sakamoto-Mizutani K, Nakajima T, Kanaami-Daibo S, Tamada Y, Shearer TR: Involvement of calpain isoforms in retinal degeneration in WBN/Kob rats. Comp Med 2004;54:533-542.
88. Kaczurowski M: Angiopathy of retinal vessels in diabetic mice. Arch Ophthalmol 1970;84:316-320.
89. Duhault J, Lebon F, Boulanger M: KK mice as a model of microangiopathic lesions in diabetes; in Ditzel J, Lewis D (eds): 7th European Conference on Microcirculation, Aberdeen. Basel, Karger, 1972, pp 453-458.
90. Cuthbertson RA, Mandel TE: The effect of murine fetal islet transplants on renal and retinal capillary basement membrane thickness. Transplant Proc 1987;19:2919-2921.
91. Agren A, Rehn G, Naeser P: Morphology and enzyme activities of the retinal capillaries in streptozotocin-diabetic mice. Acta Ophthalmol (Copenh) 1979;57:1065-1069.
92. Mohr S, Tang J, Kern TS: Caspase activation in retinas of diabetic and galactosemic mice and diabetic patients. Diabetes 2002;51:1172-1179.
93. Zheng L, Du Y, Miller C, Gubitosi-Klug RA, Ball S, Berkowitz BA, Kern TS: Critical role of inducible nitric oxide synthase in degeneration of retinal capillaries in mice with streptozotocininduced diabetes. Diabetologia 2007;50:1987-1996.
94. Gubitosi-Klug RA, Talahalli R, Du Y, Nadler JL, Kern TS: 5-Lipoxygenase, but not 12/15-lipoxygenase, contributes to degeneration of retinal capillaries in a mouse model of diabetic retinopathy. Diabetes 2008;57:1387-1393.
95. Barber AJ, Antonetti DA, Kern TS, Reiter CE, Soans RS, Krady JK, Levison SW, Gardner TW, Bronson SK: The Ins2Akita mouse as a model of early retinal complications in diabetes. Invest Ophthalmol Vis Sci 2005;46:2210-2218.
96. Kanwar M, Chan PS, Kern TS, Kowluru RA: Oxidative damage in the retinal mitochondria of diabetic mice: possible protection by superoxide dismutase. Invest Ophthalmol Vis Sci 2007;48:3805-3811.
97. Yoshioka M, Kayo T, Ikeda T, Koizumi A: A novel locus, Mody4, distal to D7Mit189 on chromosome 7 determines early-onset NIDDM in nonobese C57BL/6 (Akita) mutant mice. Diabetes 1997;46:887-894.
98. Gastinger MJ, Kunselman AR, Conboy EE, Bronson SK, Barber AJ: Dendrite remodeling and other abnormalities in the retinal ganglion cells of Ins2 Akita diabetic mice. Invest Ophthalmol Vis Sci 2008;49:2635-2642.
99. Yokote M: Retinal and renal microangiopathy in carp with spontaneous diabetes mellitus. Adv Metab Disord 1973;2(suppl 2):299-230.
100. Gleeson M, Connaughton V, Arneson LS: Induction of hyperglycaemia in zebrafish (Danio rerio) leads to morphological changes in the retina. Acta Diabetol 2007;44:157-163.
101. Clark JB, Palmer CJ, Shaw WN: The diabetic Zucker fatty rat. Proc Soc Exp Biol Med 1983;173:68-75.
102. Greenhose DD MO, Peterson RG: New models of genetically obese rats for studies in diabetes, heart disease, and complications of obesity; in Greenhouse DD, et al (eds): The Development of Fatty and Corpulent Rat Strains. Bethesda, NIH, Division of Research Service: Veterinary Resources Branch, 1988, pp 3-6.
103. Yang YS, Danis RP, Peterson RG, Dolan PL, Wu YQ: Acarbose partially inhibits microvascular retinopathy in the Zucker Diabetic Fatty rat (ZDF/Gmifa). J Ocul Pharmacol Ther 2000;16:471-479.
104. Behl Y, Krothapalli P, Desta T, DiPiazza A, Roy S, Graves DT: Diabetesenhanced tumor necrosis factor-alpha production promotes apoptosis and the loss of retinal microvascular cells in type 1 and type 2 models of diabetic retinopathy. Am J Pathol 2008;172:1411-1418.
105. Agardh CD, Agardh E, Zhang H, Ostenson CG: Altered endothelial/pericyte ratio in Goto-Kakizaki rat retina. J Diabetes Complications 1997;11:158-162.
106. Yatoh S, Mizutani M, Yokoo T, Kozawa T, Sone H, Toyoshima H, Suzuki S, Shimano H, Kawakami Y, Okuda Y, Yamada N: Antioxidants and an inhibitor of advanced glycation ameliorate death of retinal microvascular cells in diabetic retinopathy. Diabetes Metab Res Rev 2006;22:38-45.
107. Murray F, Wachowski M, Diani A, Ellis E, Grant M: Intermediate and long term diabetic (type II) complications in the spontaneously diabetic (BBZ/Wor) rat (Abstract). Diabetes 1996;45(suppl 2):272A.
108. Miyamura N, Bhutto IA, Amemiya T: Retinal capillary changes in Otsuka Long-Evans Tokushima fatty rats (spontaneously diabetic strain). Electron-microscopic study. Ophthalmic Res 1999;31:358-366.
109. Lu ZY, Bhutto IA, Amemiya T: Retinal changes in Otsuka long-evans Tokushima Fatty rats (spontaneously diabetic rat) - possibility of a new experimental model for diabetic retinopathy. Jpn J Ophthalmol 2003;47:28-35.
110. Matsuura T, Yamagishi S, Kodama Y, Shibata R, Ueda S, Narama I: Otsuka Long-Evans Tokushima fatty (OLETF) rat is not a suitable animal model for the study of angiopathic diabetic retinopathy. Int J Tissue React 2005;27:59-62.
111. Kim YH, Kim YS, Park CH, Chung IY, Yoo JM, Kim JG, Lee BJ, Kang SS, Cho GJ, Choi WS: Protein kinase C-delta mediates neuronal apoptosis in the retinas of diabetic rats via the Akt signaling pathway. Diabetes 2008;57:2181-2190.
112. Koletsky S: Animal model: obese hypertensive rat. Am J Pathol 1975;81:463-466.
113. Koletsky S: Pathologic findings and laboratory data in a new strain of obese hypertensive rats. Am J Pathol 1975;80:129-142.
114. Huang SS, Khosrof SA, Koletsky RJ, Benetz BA, Ernsberger P: Characterization of retinal vascular abnormalities in lean and obese spontaneously hypertensive rats. Clin Exp Pharmacol Physiol 1995;22(suppl 1):S129-S131.
115. Michaelis OEI, Ellwood KC, Judge JM, Schoene NW, Hansen CT: Effect of dietary sucrose on the SHR/N-corpulent rat: a new model for insulin-independent diabetes. Am J Clin Nutr 1984;39:612-618.
116. Voyles NR, Bhathena SJ, Kennedy B, Wilkins SD, Michaelis OET, Zalenski CM, Timmers KI, Recant L: Tissue somatostatin levels in three models of genetic obesity in rats. Proc Soc Exp Biol Med 1987;185:49-54.
117. McCune SA, Baker PB, Stills HF: SHHF/ Mcc-cp rat: model of obesity, non-insulin-dependent diabetes, and congestive heart failure. ILAR News 1990;32:23-37.
118. Kim SH, Chu YK, Kwon OW, McCune SA, Davidorf FH: Morphologic studies of the retina in a new diabetic model; SHR/N:Mcc-cp rat. Yonsei Med J 1998;39:453-462.
119. Midena E, Segato T, Radin S, di Giorgio G, Meneghini F, Piermarocchi S, Belloni AS: Studies on the retina of the diabetic db/db mouse. I. Endothelial cell-pericyte ratio. Ophthalmic Res 1989;21:106-111.
120. Clements RS Jr, Robison WG Jr, Cohen MP: Anti-glycated albumin therapy ameliorates early retinal microvascular pathology in db/db mice. J Diabetes Complications 1998;12:28-33.
121. Cheung AK, Fung MK, Lo AC, Lam TT, So KF, Chung SS, Chung SK: Aldose reductase deficiency prevents diabetesinduced blood-retinal barrier breakdown, apoptosis, and glial reactivation in the retina of db/db Mice. Diabetes 2005;54:3119-3125.
122. Barile GR, Pachydaki SI, Tari SR, Lee SE, Donmoyer CM, Ma W, Rong LL, Buciarelli LG, Wendt T, Horig H, Hudson BI, Qu W, Weinberg AD, Yan SF, Schmidt AM: The RAGE axis in early diabetic retinopathy. Invest Ophthalmol Vis Sci 2005;46:2916-2924.
123. Ikeda H: KK mouse. Diabetes Res Clin Pract 1994;24(suppl):S313-S316.
124. Iwatsuka H, Shino A, Suzuoki Z: General survey of diabetic features of yellow KK mice. Endocrinol Jpn 1970;17:23-35.
125. Siracusa LD: The agouti gene: turned on to yellow. Trends Genet 1994;10:423-428.
126. Herberg L, Coleman DL: Laboratory animals exhibiting obesity and diabetes syndromes. Metabolism 1977;26:59-99.
127. Ning X, Baoyu Q, Yuzhen L, Shuli S, Reed E, Li QQ: Neuro-optic cell apoptosis and microangiopathy in KKAY mouse retina. Int J Mol Med 2004;13:87-92.
128. Laver N, Robison WG Jr, Hansen BC: Spontaneously diabetic monkeys as a model for diabetic retinopathy. (ARVO Abstract). Invest Ophthalmol Vis Sci 1994;35(suppl):1733.
129. Kim SY, Johnson MA, McLeod DS, Alexander T, Otsuji T, Steidl SM, Hansen BC, Lutty GA: Retinopathy in monkeys with spontaneous type 2 diabetes. Invest Ophthalmol Vis Sci 2004;45:4543-4553.
130. Johnson MA, Lutty GA, McLeod DS, Otsuji T, Flower RW, Sandagar G, Alexander T, Steidl SM, Hansen BC: Ocular structure and function in an aged monkey with spontaneous diabetes mellitus. Exp Eye Res 2005;80:37-42.
131. Hammes HP, Wellensiek B, Kloting I, Sickel E, Bretzel RG, Brownlee M: The relationship of glycaemic level to advanced glycation end-product (AGE) accumulation and retinal pathology in the spontaneous diabetic hamster. Diabetologia 1998;41:165-170.
132. Engerman RL, Kern TS: Experimental galactosemia produces diabetic-like retinopathy. Diabetes 1984;33:97-100.
133. Kador PF, Akagi Y, Terubayashi H, Wyman M, Kinoshita JH: Prevention of pericyte ghost formation in retinal capillaries of galactose-fed dogs by aldose reductase inhibitors. Arch Ophthalmol 1988;106:1099-1102.
134. Kador PF, Akagi Y, Takahashi Y, Ikebe H, Wyman M, Kinoshita JH: Prevention of retinal vessel changes associated with diabetic retinopathy in galactosefed dogs by aldose reductase inhibitors. Arch Ophthalmol 1990;108:1301-1309.
135. Frank RN: The galactosemic dog. A valid model for both early and late stages of diabetic retinopathy. Arch Ophthalmol 1995;113:275-276.
136. Engerman RL, Kern TS: Retinopathy in galactosemic dogs continues to progress after cessation of galactosemia. Arch Ophthalmol 1995;113:355-358.
137. Kador PF, Takahashi Y, Wyman M, Ferris F III: Diabetes-like proliferative retinal changes in galactose-fed dogs. Arch Ophthalmol 1995;113:352-354.
138. Kern TS, Engerman RL: Galactoseinduced retinal microangiopathy in rats. Invest Ophthalmol Vis Sci 1995;36:490-496.
139. Neuenschwander H, Takahashi Y, Kador PF: Dose-dependent reduction of retinal vessel changes associated with diabetic retinopathy in galactose-fed dogs by the aldose reductase inhibitor M79175. J Ocul Pharmacol Ther 1997;13:517-528.
140. Kobayashi T, Kubo E, Takahashi Y, Kasahara T, Yonezawa H, Akagi Y: Retinal vessel changes in galactose-fed dogs. Arch Ophthalmol 1998;116:785-789.
141. Kador PF, Takahashi Y, Akagi Y, Neuenschwander H, Greentree W, Lackner P, Blessing K, Wyman M: Effect of galactose diet removal on the progression of retinal vessel changes in galactose-fed dogs. Invest Ophthalmol Vis Sci 2002;43:1916-1921.
142. Robison WG Jr, Nagata M, Laver N, Hohman TC, Kinoshita JH: Diabeticlike retinopathy in rats prevented with an aldose reductase inhibitor. Invest Ophthalmol Vis Sci 1989;30:2285-2292.
143. Robison WG Jr, Nagata M, Tillis TN, Laver N, Kinoshita JH: Aldose reductase and pericyte-endothelial cell contacts in retina and optic nerve. Invest Ophthalmol Vis Sci 1989;30:2293-2299.
144. Robison WG Jr, Laver NM, Jacot JL, Glover JP: Sorbinil prevention of diabetic-like retinopathy in the galactosefed rat model. Invest Ophthalmol Vis Sci 1995;36:2368-2380.
145. Robison WG Jr: Diabetic retinopathy: galactose-fed rat model. Invest Ophthalmol Vis Sci 1995;36:4A, 1743-1744.
146. Kern TS, Engerman RL: Pharmacologic inhibition of diabetic retinopathy: Aminoguanidine and aspirin. Diabetes 2001;50:1636-1642.
147. Kern TS, Engerman RL: A mouse model of diabetic retinopathy. Arch Ophthalmol 1996;114:986-990.
148. Chiou SH, Chylack LT Jr, Bunn HF, Kinoshita JH: Role of nonenzymatic glycosylation in experimental cataract formation. Biochem Biophys Res Commun 1980;95:894-901.
149. Monnier VM, Sell DR, Abdul-Karim FW, Emancipator SN: Collagen browning and cross-linking are increased in chronic experimental hyperglycemia: relevance to diabetes and aging. Diabetes 1988;37:867-872.
150. Kern TS, Kowluru R, Engerman RL: Abnormalities of retinal metabolism in diabetes or galactosemia. ATPases and glutathione. Invest Ophthalmol Vis Sci 1994;35:2962-2967.
151. Kowluru R, Kern TS, Engerman RL: Abnormalities of retinal metabolism in diabetes or galactosemia II. Comparison of gamma-glutamyl transpeptidase in retina and cerebral cortex, and effects of antioxidant therapy. Curr Eye Res 1994;13:891-896.
152. Xia P, Inoguchi T, Kern TS, Engerman RL, Oates PJ, King GL: Characterization of the mechanism for the chronic activation of DAG-PKC pathway in diabetes and hypergalactosemia. Diabetes 1994;43:1122-1129.
153. Kern TS, Kowluru RA, Engerman RL: Effect of antioxidants on the development of retinopathy in diabetes and galactosemia. Invest Ophthalmol Vis Sci 1996;37:S970.
154. Kowluru RA, Kern TS, Engerman RL: Abnormalities of retinal metabolism in diabetes or experimental galactosemia. IV. Antioxidant defense system. Free Radic Biol Med 1996;22:587-592.
155. Kowluru RA, Engerman RL, Kern TS: Abnormalities of retinal metabolism in diabetes or experimental galactosemia. VI. Comparison of retinal and cerebral cortex metabolism, and effects of antioxidant therapy. Free Radic Biol Med 1999;26:371-378.
156. Hammes HP, Martin S, Federlin K, Geisen K, Brownlee M: Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy. Proc Natl Acad Sci USA 1991;88:11555-11558.
157. Hammes HP, Brownlee M, Edelstein D, Saleck M, Martin S, Federlin K: Aminoguanidine inhibits the development of accelerated diabetic retinopathy in the spontaneous hypertensive rat. Diabetologia 1994;37:32-35.
158. Frank RN, Amin R, Kennedy A, Hohman TC: An aldose reductase inhibitor and aminoguanidine prevent vascular endothelial growth factor expression in rats with long-term galactosemia. Arch Ophthalmol 1997;115:1036-1047.
159. Yanko L, Michaelson IC, Cohen AM: The retinopathy of sucrose-fed rats. Israel J Med Sci 1972;8:1633-1636.
160. Boot-Handford R, Heath H: Identification of fructose as the retinopathic agent associated with the ingestion of sucrose-rich diets in the rat. Metabolism 1980;29:1247-1252.
161. Tolentino MJ, Miller JW, Gragoudas ES, Jakobiec FA, Flynn E, Chatzistefanou K, Ferrara N, Adamis AP: Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate. Ophthalmology 1996;103:1820-1828.
162. Ruberte J, Ayuso E, Navarro M, Carretero A, Nacher V, Haurigot V, George M, Llombart C, Casellas A, Costa C, Bosch A, Bosch F: Increased ocular levels of IGF-1 in transgenic mice lead to diabetes-like eye disease. J Clin Invest 2004;113:1149-1157.
163. Danis RP, Bingaman DP: Insulin-like growth factor-1 retinal microangiopathy in the pig eye. Ophthalmology 1997;104:1661-1669.
164. Benjamin LE, Hemo I, Keshet E: A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. Development 1998;125:1591-1598.
165. Lindahl P, Johansson BR, Leveen P, Betsholtz C: Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science 1997;277:242-245.
166. Enge M, Bjarnegard M, Gerhardt H, Gustafsson E, Kalen M, Asker N, Hammes HP, Shani M, Fassler R, Betsholtz C: Endothelium-specific plateletderived growth factor-B ablation mimics diabetic retinopathy. EMBO J 2002;21:4307-4316.
167. Hammes HP, Lin J, Renner O, Shani M, Lundqvist A, Betsholtz C, Brownlee M, Deutsch U: Pericytes and the pathogenesis of diabetic retinopathy. Diabetes 2002;51:3107-3112.
168. Mori K, Gehlbach P, Ando A, Dyer G, Lipinsky E, Chaudhry AG, Hackett SF, Campochiaro PA: Retina-specific expression of PDGF-B versus PDGF-A: vascular versus nonvascular proliferative retinopathy. Invest Ophthalmol Vis Sci 2002;43:2001-2006.
169. Wiley LA, Rupp GR, Steinle JJ: Sympathetic innervation regulates basement membrane thickening and pericyte number in rat retina. Invest Ophthalmol Vis Sci 2005;46:744-748.
170. Steinle JJ, Lindsay NL, Lashbrook BL: Cervical sympathectomy causes photoreceptor-specific cell death in the rat retina. Auton Neurosci 2005;120:46-51.
171. Steinle JJ, Smith PG: Sensory but not parasympathetic nerves are required for ocular vascular remodeling following chronic sympathectomy in rat. Auton Neurosci 2003;109:34-41.
172. Steinle JJ, Pierce JD, Clancy RL, P GS: Increased ocular blood vessel numbers and sizes following chronic sympathectomy in rat. Exp Eye Res 2002;74:761-768.
173. Zheng L, Gong B, Hatala DA, Kern TS: Retinal ischemia and reperfusion causes capillary degeneration: similarities to diabetes. Invest Ophthalmol Vis Sci 2007;48:361-367.
174. Moravski CJ, Skinner SL, Stubbs AJ, Sarlos S, Kelly DJ, Cooper ME, Gilbert RE, Wilkinson-Berka JL: The reninangiotensin system influences ocular endothelial cell proliferation in diabetes: transgenic and interventional studies. Am J Pathol 2003;162:151-160.